Ann: Acquisition of Telerhythmics LLC, page-317

Hi all. Yes it's all great that we have an approved product and approved factory and yes a huge about of time and work has gone into this. Yes it's a credit to yacov and his team. But the point I keep making is MOUs in general are not worth the paper they are written on. I have seen company's announce MOUs and nothing ever happens. Will GMV be different? Probably not. Some will come off, some won't and some will be variations of the initial announcement. Bottom line is it's now time for GMV to delivery on the revenue front. All the hard work has been done getting an approved product and factory ready to go. GMV states in its March response to the asx that the medtell mou is only waiting on approval for the Chinese factory. Now that the factory is approved it has to announce if medtell are going ahead or not. This whilst a very small contract in the scheme of things it is the single most important announcement imo. It will tell the market how creditable yacov and his team are in terms of executing contracts and generating revenue. They have already announced problems with the fcl mou. As previously stated the hk and nasdaq ipos will not go ahead until the company generates revenue. Yes we are all lths and believe in the product, addressable market, management and the direction of the company. But without a contract in the very short term who knows how low the sp will go. As investors we need to keep a level head and way up the risks both positive and negative. Why do you think the sp is 27c?